It’s important to determine the expression status of estrogen receptor (ER), progesterone receptor (PR), and HER2 in BC, because they are associated with prognosis, endocrine therapies, and adjuvant treatment decisions [2, 3]. This evidence concerns the gene PGR and breast cancer.